Silk Road Medical Inc. (SILK) Reports In-Line Q4 EPS, Revenues Beat; Provides FY20 Revenue Guidance
Go back to Silk Road Medical Inc. (SILK) Reports In-Line Q4 EPS, Revenues Beat; Provides FY20 Revenue Guidance| (NASDAQ: SILK) | Delayed: 27.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.49 | 52 Week High | $ | |||
| Open | $27.49 | 52 Week Low | $ | |||
| Day High | $27.49 | P/E | N/A | |||
| Day Low | $27.49 | EPS | $ | |||
| Volume | 167 | |||||

